Clinical features of 78 adults with 22q11 deletion syndrome

22q11 Deletion Syndrome (22q11DS) is a common microdeletion syndrome with multisystem expression. Phenotypic features vary with age, ascertainment, and assessment. We systematically assessed 78 adults (36 M, 42 F; mean age 31.5, SD 10.5 years) with a 22q11.2 deletion ascertained through an adult congenital cardiac clinic (n = 35), psychiatric‐related sources (n = 39), or as affected parents of subjects (n = 4). We recorded the lifetime prevalence of features requiring attention, with 95% confidence intervals (CI) not overlapping zero. Subtle learning difficulties, hypernasality and facial gestalt were not included. We investigated ascertainment effects using non‐overlapping subgroups ascertained with tetralogy of Fallot (n = 31) or schizophrenia (n = 31). Forty‐three features met inclusion criteria and were present in 5% or more patients, including several of later onset (e.g., hypothyroidism, cholelithiasis). Number of features per patient (median 9, range 3–22) correlated with hospitalizations (P = 0.0002) and, when congenital features were excluded, with age (P = 0.02). Adjusting for ascertainment, 25.8% (95% CI, 9.5–42.1%) of patients had cardiac anomalies and 22.6% (95% CI, 7.0–38.2%) had schizophrenia. Ascertainment subgroups were otherwise similar in median number and prevalence of features. Non‐characteristic features are common in 22q11DS. Adjusting for ascertainment effects is important. Many treatable conditions may be anticipated and features may accumulate over time. The results have implications for clinical assessment and management, genetic counseling and research into pathophysiological mechanisms. © 2005 Wiley‐Liss, Inc.

[1]  A. Rope,et al.  Genetic analyses in two extended families with deletion 22q11 syndrome: importance of extracardiac manifestations. , 2005, The Journal of pediatrics.

[2]  C. Persson,et al.  Presenting phenotype in 100 children with the 22q11 deletion syndrome , 2005, European Journal of Pediatrics.

[3]  Joe C. Adams,et al.  Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. , 2004, Human molecular genetics.

[4]  G. Conway Considerations for transition from paediatric to adult endocrinology: women with Turner's syndrome. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[5]  J. Lieberman,et al.  A comprehensive analysis of 22q11 gene expression in the developing and adult brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Minoshima,et al.  Role of TBX1 in human del22q11.2 syndrome , 2003, The Lancet.

[7]  Rosanna Weksberg,et al.  The schizophrenia phenotype in 22q11 deletion syndrome. , 2003, The American journal of psychiatry.

[8]  H. Cox,et al.  22q11 deletion: a multisystem disorder requiring multidisciplinary input , 2003, Archives of disease in childhood.

[9]  J. Souberbielle,et al.  Parathyroid function and growth in 22q11.2 deletion syndrome. , 2003, The Journal of pediatrics.

[10]  R. Weksberg,et al.  Patterns of dysmorphic features in schizophrenia. , 2001, American journal of medical genetics.

[11]  E. Lindsay Chromosomal microdeletions: dissecting del22q11 syndrome , 2001, Nature reviews genetics.

[12]  C. Ogilvie,et al.  Velopharyngeal incompetence and chromosome 22q11 deletion , 2001, The Lancet.

[13]  A. Bassett,et al.  Genetic Counselling for Schizophrenia in the Era of Molecular Genetics , 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[14]  S. Weinzimer Endocrine aspects of the 22q11.2 deletion syndrome , 2001, Genetics in Medicine.

[15]  M. Digilio,et al.  Auxological evaluation in patients with DiGeorge/velocardiofacial syndrome (deletion 22q11.2 syndrome) , 2001, Genetics in Medicine.

[16]  E. Zackai,et al.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net! , 2001, Genetics in Medicine.

[17]  R. Matsuoka,et al.  Tetralogy of Fallot associated with chromosome 22q11.2 deletion in adolescents and young adults , 2001, Genetics in Medicine.

[18]  P. Scambler The 22q11 deletion syndromes. , 2000, Human molecular genetics.

[19]  C D Naylor,et al.  Users' guides to the medical literature: XXIV. How to use an article on the clinical manifestations of disease. Evidence-Based Medicine Working Group. , 2000, JAMA.

[20]  K. Devriendt,et al.  Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. , 2000, American journal of medical genetics.

[21]  R. Weksberg,et al.  Chromosomal abnormalities and schizophrenia. , 2000, American journal of medical genetics.

[22]  M. Owen,et al.  High rates of schizophrenia in adults with velo-cardio-facial syndrome (VCFS) , 1999, Schizophrenia Research.

[23]  R. Weksberg,et al.  Phenotype of adults with the 22q11 deletion syndrome: A review. , 1999, American journal of medical genetics.

[24]  J. Burn,et al.  Frequency and predictive value of 22q11 deletion , 1999, Journal of medical genetics.

[25]  A. Bassett,et al.  22q11 deletion syndrome: a genetic subtype of schizophrenia , 1999, Biological Psychiatry.

[26]  E. Zackai,et al.  The Philadelphia story: the 22q11.2 deletion: report on 250 patients. , 1999, Genetic counseling.

[27]  P. Calvas,et al.  22q11 deletion in DGS/VCFS monozygotic twins with discordant phenotypes. , 1999, Genetic counseling.

[28]  K. Devriendt,et al.  Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. , 1999, Genetic counseling.

[29]  I. Cross,et al.  A population study of chromosome 22q11 deletions in infancy , 1998, Archives of disease in childhood.

[30]  R. Weksberg,et al.  22q11 deletion syndrome in adults with schizophrenia. , 1998, American journal of medical genetics.

[31]  B. Morrow,et al.  Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome , 1998, Human Genetics.

[32]  A. Green,et al.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. , 1997, Journal of medical genetics.

[33]  B. Emanuel,et al.  Progress in the autosomal segmental aneusomy syndromes (SASs): single or multi-locus disorders? , 1997, Human molecular genetics.

[34]  L. Shaffer,et al.  Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region. , 1993, American journal of medical genetics.

[35]  E. Zackai,et al.  Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. , 1993, Journal of medical genetics.

[36]  P. Scambler,et al.  DiGeorge syndrome: part of CATCH 22. , 1993, Journal of medical genetics.

[37]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[38]  R. Shprintzen,et al.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. , 1978, The Cleft palate journal.